Pence H, Kilic E, Elibol B, Kuras S, Guzel M, Buyuk Y
Exp Brain Res. 2024; 243(1):24.
PMID: 39671092
DOI: 10.1007/s00221-024-06972-y.
Song S, Kim S, Jang W, Ryu I, Jeong C, Lee S
Sci Rep. 2024; 14(1):22543.
PMID: 39343795
PMC: 11439939.
DOI: 10.1038/s41598-024-73247-5.
Wells A, Lotfipour S
Adv Drug Alcohol Res. 2024; 3:11628.
PMID: 38389806
PMC: 10880762.
DOI: 10.3389/adar.2023.11628.
Ma K, Pham T, Wang J, O-Sullivan I, DiCamillo A, Du S
Sci Adv. 2024; 10(7):eadi5501.
PMID: 38354243
PMC: 10866538.
DOI: 10.1126/sciadv.adi5501.
Mohammad Aghaei A, Saali A, Canas M, Weleff J, DSouza D, Angarita G
Psychiatry Res. 2023; 330:115586.
PMID: 37931479
PMC: 10842415.
DOI: 10.1016/j.psychres.2023.115586.
Modulation of social and depression behaviors in cholestatic and drug-dependent mice: possible role of opioid receptors.
Khakpai F, Rezaei N, Issazadeh Y, Zarrindast M
J Diabetes Metab Disord. 2023; 22(1):275-285.
PMID: 37255824
PMC: 10225439.
DOI: 10.1007/s40200-022-01129-6.
Sex/Gender Differences in the Time-Course for the Development of Substance Use Disorder: A Focus on the Telescoping Effect.
Towers E, Williams I, Qillawala E, Rissman E, Lynch W
Pharmacol Rev. 2023; 75(2):217-249.
PMID: 36781217
PMC: 9969523.
DOI: 10.1124/pharmrev.121.000361.
Place conditioning in humans: opportunities for translational research.
Krishnan S, Bevins R, de Wit H
Psychopharmacology (Berl). 2023; 240(11):2221-2230.
PMID: 36656336
PMC: 10949408.
DOI: 10.1007/s00213-023-06316-8.
Age-Dependent and Pathway-Specific Bimodal Action of Nicotine on Synaptic Plasticity in the Hippocampus of Mice Lacking the miR-132/212 Genes.
Stojanovic T, Velarde Gamez D, Schuld G, Bormann D, Cabatic M, Uhrin P
Cells. 2022; 11(2).
PMID: 35053378
PMC: 8774101.
DOI: 10.3390/cells11020261.
The IntelliCage System: A Review of Its Utility as a Novel Behavioral Platform for a Rodent Model of Substance Use Disorder.
Iman I, Mohd Yusof N, Talib U, Ahmad N, Norazit A, Kumar J
Front Behav Neurosci. 2021; 15:683780.
PMID: 34149373
PMC: 8211779.
DOI: 10.3389/fnbeh.2021.683780.
Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities.
Namba M, Leyrer-Jackson J, Nagy E, Olive M, Neisewander J
Front Neurosci. 2021; 15:650785.
PMID: 33935636
PMC: 8082184.
DOI: 10.3389/fnins.2021.650785.
An autophagy-related protein Becn2 regulates cocaine reward behaviors in the dopaminergic system.
Kim Y, Kong Q, Yamamoto S, Kuramoto K, Huang M, Wang N
Sci Adv. 2021; 7(8).
PMID: 33608268
PMC: 7895433.
DOI: 10.1126/sciadv.abc8310.
Social isolation at adolescence: a systematic review on behaviour related to cocaine, amphetamine and nicotine use in rats and mice.
Noschang C, Lampert C, Krolow R, de Almeida R
Psychopharmacology (Berl). 2021; 238(4):927-947.
PMID: 33606060
DOI: 10.1007/s00213-021-05777-z.
Prenatal opioid exposure and vulnerability to future substance use disorders in offspring.
Abu Y, Roy S
Exp Neurol. 2021; 339:113621.
PMID: 33516730
PMC: 8012222.
DOI: 10.1016/j.expneurol.2021.113621.
Oxycodone in the Opioid Epidemic: High 'Liking', 'Wanting', and Abuse Liability.
Kibaly C, Alderete J, Liu S, Nasef H, Law P, Evans C
Cell Mol Neurobiol. 2020; 41(5):899-926.
PMID: 33245509
PMC: 8155122.
DOI: 10.1007/s10571-020-01013-y.
An optimized procedure for robust volitional cocaine intake in mice.
Lopez A, Johnson A, Kunnath A, Morris A, Zachry J, Thibeault K
Exp Clin Psychopharmacol. 2020; 29(4):319-333.
PMID: 32658535
PMC: 7890946.
DOI: 10.1037/pha0000399.
Pharmacological Inactivation of Medial Prefrontal Cortex Does Not Support Dichotomous "Go/Stop" Roles for Dorsal and Ventral Subdivisions in Natural Reward Seeking in Rats.
Carney R
eNeuro. 2020; 7(4).
PMID: 32646921
PMC: 8114868.
DOI: 10.1523/ENEURO.0246-20.2020.
Rewarding Effect of (Khat) and the Sex Differences to the Responses in Swiss Albino Mice.
Limenie A, Tolessa T, Makonnen E, Seifu D
Psychol Res Behav Manag. 2020; 13:279-289.
PMID: 32273781
PMC: 7106998.
DOI: 10.2147/PRBM.S242036.
How preclinical studies have influenced novel psychoactive substance legislation in the UK and Europe.
Santos-Toscano R, Guirguis A, Davidson C
Br J Clin Pharmacol. 2020; 86(3):452-481.
PMID: 32045495
PMC: 7080617.
DOI: 10.1111/bcp.14224.
Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys.
Zamarripa C, Naylor J, Huskinson S, Townsend E, Prisinzano T, Freeman K
Psychopharmacology (Berl). 2020; 237(5):1471-1480.
PMID: 32006048
PMC: 7196516.
DOI: 10.1007/s00213-020-05473-4.